| 000 | 01821 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514222420.0 | ||
| 264 | 0 | _c20050801 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2004-09-3523 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMesa, Ruben A | |
| 245 | 0 | 0 |
_aHeat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. _h[electronic resource] |
| 260 |
_bBlood _cJul 2005 |
||
| 300 |
_a318-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aBenzoquinones |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLactams, Macrocyclic |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinases _xgenetics |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 |
_aRifabutin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aS Phase _xdrug effects |
| 700 | 1 | _aLoegering, David | |
| 700 | 1 | _aPowell, Heather L | |
| 700 | 1 | _aFlatten, Karen | |
| 700 | 1 | _aArlander, Sonnet J H | |
| 700 | 1 | _aDai, Nga T | |
| 700 | 1 | _aHeldebrant, Michael P | |
| 700 | 1 | _aVroman, Benjamin T | |
| 700 | 1 | _aSmith, B Douglas | |
| 700 | 1 | _aKarp, Judith E | |
| 700 | 1 | _aEyck, Cynthia J Ten | |
| 700 | 1 | _aErlichman, Charles | |
| 700 | 1 | _aKaufmann, Scott H | |
| 700 | 1 | _aKarnitz, Larry M | |
| 773 | 0 |
_tBlood _gvol. 106 _gno. 1 _gp. 318-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2004-09-3523 _zAvailable from publisher's website |
| 999 |
_c15456534 _d15456534 |
||